T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55

We assessed T-cell responses in young osteosarcoma patients vaccinated with 105AD7, 1-6 months after having received chemotherapy. 105AD7 is a human anti-idiotypic antibody mimicking CD55, a glycoprotein that protects from attack by complement and which is overexpressed on osteosarcoma cells. Seven...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.). - 1999. - 128(2008), 2 vom: 15. Aug., Seite 148-54
1. Verfasser:	Ullenhag, G J (VerfasserIn)
Weitere Verfasser:	Spendlove, I, Watson, N F S, Kallmeyer, C, Pritchard-Jones, K, Durrant, L G
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2008
Zugriff auf das übergeordnete Werk:	Clinical immunology (Orlando, Fla.)
Schlagworte:	Clinical Trial Clinical Trial, Phase I Clinical Trial, Phase II Journal Article Multicenter Study Research Support, Non-U.S. Gov't 105AD7 antibody Antibodies, Anti-Idiotypic Antibodies, Monoclonal CD55 Antigens mehr... Cancer Vaccines Tumor Necrosis Factor-alpha Interferon-gamma 82115-62-6 Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1